ストックスクリーナーアプリを入手
3.76
2.84%
-0.11
アフターアワーズ：
3.76
前日終値:
$3.87
開ける：
$3.86
24時間の取引高:
262.89K
Relative Volume:
2.33
時価総額：
$58.18M
収益：
-
当期純損益:
$-10.31M
株価収益率:
-4.8831
EPS:
-0.77
ネットキャッシュフロー:
$-12.65M
1週間 パフォーマンス:
-8.74%
1か月 パフォーマンス:
+8.05%
6か月 パフォーマンス:
+17.50%
1年 パフォーマンス:
+32.39%
1日の値動き範囲:
$3.58
$3.86
1週間の範囲:
$3.58
$4.30
52週間の値動き範囲:
$1.75
$4.30
Grace Therapeutics Inc Stock (GRCE) Company Profile
Compare GRCE vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GRCE
Grace Therapeutics Inc
|
3.76 | 59.88M | 0 | -10.31M | -12.65M | -0.77 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Grace Therapeutics Inc Stock (GRCE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-05-02 | 開始されました | TD Cowen | Buy |
| 2020-09-01 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2020-07-06 | アップグレード | B. Riley FBR | Neutral → Buy |
| 2020-01-13 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2019-08-29 | 開始されました | B. Riley FBR | Buy |
| 2019-07-18 | 開始されました | Oppenheimer | Outperform |
| 2019-06-26 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Grace Therapeutics Inc (GRCE) 最新ニュース
GRCE SEC FilingsGrace Therapeutics, Inc 10-K, 10-Q, 8-K Forms - Stock Titan
GRCE: IV nimodipine shows superior efficacy and compliance over oral forms for aSAH treatment - TradingView
Institution Moves: What is Grace Therapeutics Incs valuation compared to sector2025 Trade Ideas & Safe Entry Zone Tips - baoquankhu1.vn
Is OXLC.G forming a breakout patternPortfolio Performance Report & Free Daily Entry Point Trade Alerts - mfd.ru
Rate Hike: Can Grace Therapeutics Inc weather a recessionProfit Target & Reliable Price Action Trade Plans - baoquankhu1.vn
Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Update - MarketBeat
ANTX PE Ratio & Valuation, Is ANTX Overvalued - Intellectia AI
PYPD PE Ratio & Valuation, Is PYPD Overvalued - Intellectia AI
GRCE Should I Buy - Intellectia AI
Buy Signal: Is MSAI forming a breakout pattern2025 Trading Volume Trends & Expert Approved Momentum Ideas - baoquankhu1.vn
Grace Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - Bitget
Grace CEO joins TD Cowen event with IV nimodipine program - Stock Titan
Stop Loss: Does CRVS stock benefit from AI growthWeekly Trade Report & Fast Momentum Stock Entry Tips - baoquankhu1.vn
NVIDIA Corporation (NVDA) to Supply Standalone Grace CPUs in Landmark Data Center Rollout - Yahoo Finance
Companies Like Grace Therapeutics (NASDAQ:GRCE) Are In A Position To Invest In Growth - Sahm
Moderna | History, Innovation, Challenges, & Facts | Britannica Money - Britannica
ADAR1 discloses 9.9% Grace Therapeutics (GRCE) ownership in 13G/A - Stock Titan
Aug PreEarnings: Is Grace Therapeutics Inc a turnaround storyMarket Risk Report & Stepwise Entry and Exit Trade Signals - baoquankhu1.vn
SAPMY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Can MetaVia Inc. stock outperform in a bear marketTreasury Yields & Proven Capital Preservation Methods - mfd.ru
Will Grace Therapeutics Inc. stock sustain high P E ratios2025 Technical Patterns & Daily Growth Stock Investment Tips - mfd.ru
Does Grace Therapeutics Inc. have a sustainable dividend2025 Volume Leaders & Real-Time Volume Surge Alerts - mfd.ru
Is EVGOW stock a top momentum playPortfolio Update Report & Daily Entry Point Alerts - mfd.ru
Is SFYX stock good for wealth creation2025 Price Momentum & Real-Time Volume Analysis - mfd.ru
GRCE PE Ratio & Valuation, Is GRCE Overvalued - Intellectia AI
BOL.ST Should I Buy - Intellectia AI
Analysts Are Bullish on Top Healthcare Stocks: Grace Therapeutics (GRCE), Alto Neuroscience, Inc. (ANRO) - The Globe and Mail
Is Grace Therapeutics Inc. still a buy after recent gainsWeekly Trading Summary & Technical Pattern Alert System - mfd.ru
Nantahala discloses 9.99% Grace Therapeutics (NASDAQ: GRCE) stake - Stock Titan
Grace Therapeutics announces third quarter 2026 financial results, provides business update - marketscreener.com
Grace Therapeutics (NASDAQ:GRCE) Announces Earnings Results - MarketBeat
Grace Therapeutics (GRCE) Advances Towards FDA Review with Promi - GuruFocus
Is Grace Therapeutics Inc. a cyclical or defensive stockWeekly Stock Summary & Accurate Trade Setup Notifications - mfd.ru
Grace: Fiscal Third Quarter Earnings Overview - Bitget
Grace: Fiscal Q3 Earnings Snapshot - kare11.com
Grace Therapeutics Announces Third Quarter 2026 Financial Results, Provides Business Update - The Manila Times
Grace Therapeutics Q3 2026 Financial Results and Business Update - TradingView
April 23 FDA target date set for Grace’s GTx-104 aSAH drug - Stock Titan
Grace Therapeutics, Inc. SEC 10-Q Report - TradingView
Why is Grace Therapeutics Inc. stock going upShort Setup & Verified Trade Idea Suggestions - mfd.ru
Jobs Data: Can Grace Therapeutics Inc weather a recession2025 Sector Review & Expert-Curated Trade Recommendations - baoquankhu1.vn
Aug Selloffs: What are the risks of holding BioXcel Therapeutics Inc.Weekly Volume Report & Consistent Growth Stock Picks - mfd.ru
Grace Therapeutics (GRCE) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Volatility Watch: Can SolarBank Corporation generate free cash flowJuly 2025 Opening Moves & Technical Analysis for Trade Confirmation - baoquankhu1.vn
Aug Fed Impact: Why is Grace Therapeutics Inc stock going upMarket Trend Review & Smart Allocation Stock Tips - baoquankhu1.vn
Quarterly Recap: Does IMMR stock benefit from AI growthMarket Growth Review & Fast Momentum Entry Tips - baoquankhu1.vn
Grace Therapeutics, Inc. (NASDAQ:GRCE) Short Interest Up 34.6% in January - MarketBeat
Dividend Watch: Is ETRACS 2xMonthly Pay Leveraged Index ETN benefiting from interest rate changesMarket Risk Report & Capital Protection Trade Alerts - baoquankhu1.vn
Gainers Report: Can Grace Therapeutics Inc weather a recessionTake Profit & Free Daily Entry Point Trade Alerts - baoquankhu1.vn
New Highs: Is Grupo Supervielle SA Depositary Receipt a strong candidate for buy and holdJuly 2025 News Drivers & Stepwise Trade Execution Plans - baoquankhu1.vn
What is Chicago Atlantic Real Estate Finance Inc. s 5 year growth outlookJuly 2025 Selloffs & Stepwise Trade Execution Plans - mfd.ru
Grace Therapeutics Inc (GRCE) 財務データ
収益
当期純利益
現金流量
EPS
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):